(Q39890868)

15 September 2017

title

Metabolic abnormalities in human immunodeficiency virus-infected children: two-year follow-up (English)

1 reference

15 September 2017

Jens C Krause

1

1 reference

15 September 2017

Mary P Toye

2

1 reference

15 September 2017

Donna J Fisher

3

1 reference

15 September 2017

Barbara W Stechenberg

4

1 reference

15 September 2017

Edward O Reiter

5

1 reference

15 September 2017

Holley F Allen

6

1 reference

15 September 2017

publication date

1 April 2009

1 reference

Journal of Pediatric Endocrinology and Metabolism

15 September 2017

published in

1 reference

15 September 2017

volume

22

1 reference

15 September 2017

issue

4

1 reference

15 September 2017

page(s)

345-351

1 reference

Evidence of human immunodeficiency virus-associated lipodystrophy syndrome in children treated with protease inhibitors.

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.4.345

Obesity and the metabolic syndrome in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.4.345

Serum adiponectin and leptin concentrations in HIV-infected children with fat redistribution syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.4.345

Effects of highly active antiretroviral therapy on paediatric metabolite levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.4.345

Hypertriglyceridemia and hypercholesterolemia in human immunodeficiency virus-1-infected children treated with protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.4.345

Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.4.345

Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.4.345

Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.4.345

Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.4.345

Low plasma level of adiponectin is associated with stavudine treatment and lipodystrophy in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.4.345

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.4.345

Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.4.345

Endocrine abnormalities and impaired growth in human immunodeficiency virus-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.4.345

10.1515/JPEM.2009.22.4.345

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference